Pérez de Los Cobos José, Trujols Joan, Valderrama Juan Carlos, Valero Sergi, Puig Teresa
Addictive Behaviours Unit, Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona Autonomous University School of Medicine, Sant Antoni M(a) Claret 167, 08025 Barcelona, Spain.
Drug Alcohol Depend. 2005 Sep 1;79(3):405-12. doi: 10.1016/j.drugalcdep.2005.03.021.
Desired adjustment of methadone dose, perceived participation in dosage regulation, and satisfaction with methadone treatment centres were assessed in a sample of opioid-dependent patients from the Valencia Region (eastern Spain). An independent interviewer asked 278 consecutively arriving patients to answer the survey, and 165 (59.4%) completed it. Adjustment of methadone dose was assessed with a -10 to +10 visual analogue scale (VAS-MD); participation in methadone dose regulation, with specific questions; and patient satisfaction, with the Verona Service Satisfaction Scale for methadone treatment (VSSS-MT). The methadone dose (mg/d) prescribed by physicians was (mean+/-S.D.) 68.0+/-30.4. Participants scored -1.0+/-4.7 on the VAS-MD, indicating a significant downward desired adjustment of methadone dose (95% CI of -1.73 to -0.30). Of the patients surveyed, approximately one-third were, overall, content with their participation in methadone dose regulation. Overall, participants felt slightly satisfied (VSSS-MT=3.5+/-0.6) with the centres. Patients treated with a methadone dose of < 60 mg/d felt more satisfied than those treated with 60-100 mg/d. Information about dose changes was the only continuous methadone dose variable related with satisfaction that was found in a multiple regression analysis, which accounted for only 2.0% of the variance in VSSS-MT overall scores. In conclusion, patients' opinions on methadone dose and patient satisfaction are only very weakly related when methadone treatment is implemented as in the Valencia Region.
在来自西班牙东部巴伦西亚地区的阿片类药物依赖患者样本中,评估了美沙酮剂量的期望调整、在剂量调整中的感知参与度以及对美沙酮治疗中心的满意度。一名独立访谈者要求278名连续前来的患者回答调查问卷,其中165名(59.4%)完成了调查。美沙酮剂量的调整采用-10至+10的视觉模拟量表(VAS-MD)进行评估;美沙酮剂量调整的参与度通过特定问题进行评估;患者满意度则采用美沙酮治疗的维罗纳服务满意度量表(VSSS-MT)进行评估。医生开具的美沙酮剂量(mg/d)为(均值±标准差)68.0±30.4。参与者在VAS-MD上的得分为-1.0±4.7,表明美沙酮剂量存在显著的期望下调(95%置信区间为-1.73至-0.30)。在接受调查的患者中,总体而言,约三分之一的患者对自己参与美沙酮剂量调整感到满意。总体而言,参与者对这些中心感到略有满意(VSSS-MT = 3.5±0.6)。接受美沙酮剂量<60 mg/d治疗的患者比接受60-100 mg/d治疗的患者感觉更满意。在多元回归分析中发现,关于剂量变化的信息是与满意度相关的唯一连续美沙酮剂量变量,其仅占VSSS-MT总分方差的2.0%。总之,在巴伦西亚地区实施美沙酮治疗时,患者对美沙酮剂量的看法与患者满意度之间的关联非常微弱。